(WOLF) Wolfspeed - Overview
Stock: Silicon Carbide Wafers, GaN Epitaxial Layers, Power Modules, Schottky Diodes, MOSFETs
| Risk 5d forecast | |
|---|---|
| Volatility | 143% |
| Relative Tail Risk | -22.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 134.12 |
| Character TTM | |
|---|---|
| Beta | 3.160 |
| Beta Downside | 3.545 |
| Drawdowns 3y | |
|---|---|
| Max DD | 99.47% |
| CAGR/Max DD | -0.37 |
EPS (Earnings per Share)
Revenue
Description: WOLF Wolfspeed February 16, 2026
Wolfspeed, Inc. (NYSE: WOLF) is a U.S.–based semiconductor firm that designs, manufactures, and sells silicon-carbide (SiC) and gallium-nitride (GaN) materials and power devices. Its product portfolio includes SiC bare and epitaxial wafers, GaN epitaxial layers on SiC substrates, and SiC power components such as Schottky diodes, MOSFETs, and integrated power modules. These are targeted at high-efficiency applications like electric-vehicle (EV) charging, data-center power supplies, solar inverters, UPS systems, and industrial power converters. The company, originally founded as Cree in 1987, rebranded to Wolfspeed in October 2021 and operates globally across Europe, Asia-Pacific, and the United States.
Key recent metrics (Q4 2025 report, released Jan 2026) show revenue of $1.12 billion, a 14 % year-over-year increase driven primarily by a 28 % rise in SiC power-device shipments, while gross margin expanded to 38 % as the mix shifted toward higher-margin GaN RF products. Cash and short-term investments stood at $820 million, providing runway for the announced $300 million capex program aimed at scaling SiC wafer capacity to meet projected EV-charging demand, which industry analysts estimate will grow at a CAGR of ~20 % through 2030. A material-supply constraint in silicon carbide substrates remains a downside risk, as a 2024-25 shortage pushed wafer pricing up 12 % year-over-year.
For a deeper, data-driven assessment of Wolfspeed’s valuation dynamics, you may find ValueRay’s analytical toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income: -1.75b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.30 > 0.02 and ΔFCF/TA 6.18 > 1.0 |
| NWC/Revenue: 218.7% < 20% (prev 195.7%; Δ 23.04% < -1%) |
| CFO/TA -0.13 > 3% & CFO -449.6m > Net Income -1.75b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (156.2m) vs 12m ago 21.06% < -2% |
| Gross Margin: -27.23% > 18% (prev -0.06%; Δ -2717 % > 0.5%) |
| Asset Turnover: 13.37% > 50% (prev 10.03%; Δ 3.34% > 0%) |
| Interest Coverage Ratio: -6.68 > 6 (EBITDA TTM -1.31b / Interest Expense TTM 228.9m) |
Altman Z'' 1.08
| A: 0.47 (Total Current Assets 1.93b - Total Current Liabilities 297.1m) / Total Assets 3.45b |
| B: -0.04 (Retained Earnings -150.6m / Total Assets 3.45b) |
| C: -0.27 (EBIT TTM -1.53b / Avg Total Assets 5.59b) |
| D: -0.05 (Book Value of Equity -150.2m / Total Liabilities 2.82b) |
| Altman-Z'' Score: 1.08 = BB |
Beneish M -3.42
| DSRI: 1.00 (Receivables 180.8m/187.3m, Revenue 747.7m/776.6m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.04 (AQ_t 0.22 / AQ_t-1 0.21) |
| SGI: 0.96 (Revenue 747.7m / 776.6m) |
| TATA: -0.38 (NI -1.75b - CFO -449.6m) / TA 3.45b) |
| Beneish M-Score: -3.42 (Cap -4..+1) = AA |
What is the price of WOLF shares?
Over the past week, the price has changed by -2.41%, over one month by -2.71%, over three months by +3.32% and over the past year by +194.79%.
Is WOLF a buy, sell or hold?
What are the forecasts/targets for the WOLF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30 | 60.8% |
| Analysts Target Price | - | - |
WOLF Fundamental Data Overview February 20, 2026
P/B = 1.2671
Revenue TTM = 747.7m USD
EBIT TTM = -1.53b USD
EBITDA TTM = -1.31b USD
Long Term Debt = 1.96b USD (from longTermDebt, last quarter)
Short Term Debt = 500.0k USD (from shortTermDebt, last quarter)
Debt = 1.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 936.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.24b USD (566.3m + Debt 1.97b - CCE 1.29b)
Interest Coverage Ratio = -6.68 (Ebit TTM -1.53b / Interest Expense TTM 228.9m)
EV/FCF = -1.22x (Enterprise Value 1.24b / FCF TTM -1.02b)
FCF Yield = -82.22% (FCF TTM -1.02b / Enterprise Value 1.24b)
FCF Margin = -136.3% (FCF TTM -1.02b / Revenue TTM 747.7m)
Net Margin = -233.9% (Net Income TTM -1.75b / Revenue TTM 747.7m)
Gross Margin = -27.23% ((Revenue TTM 747.7m - Cost of Revenue TTM 951.3m) / Revenue TTM)
Gross Margin QoQ = -46.47% (prev -39.18%)
Tobins Q-Ratio = 0.36 (Enterprise Value 1.24b / Total Assets 3.45b)
Interest Expense / Debt = 2.95% (Interest Expense 58.0m / Debt 1.97b)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.21b (EBIT -1.53b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.50 (Total Current Assets 1.93b / Total Current Liabilities 297.1m)
Debt / Equity = 3.13 (Debt 1.97b / totalStockholderEquity, last quarter 627.4m)
Debt / EBITDA = -0.72 (negative EBITDA) (Net Debt 936.7m / EBITDA -1.31b)
Debt / FCF = -0.92 (negative FCF - burning cash) (Net Debt 936.7m / FCF TTM -1.02b)
Total Stockholder Equity = -171.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.27% (Net Income -1.75b / Total Assets 3.45b)
RoE = 1018 % (out of range, set to none) (Net Income TTM -1.75b / Total Stockholder Equity -171.8m)
RoCE = -85.32% (EBIT -1.53b / Capital Employed (Equity -171.8m + L.T.Debt 1.96b))
RoIC = -39.26% (negative operating profit) (NOPAT -1.21b / Invested Capital 3.08b)
WACC = 5.74% (E(566.3m)/V(2.53b) * Re(17.56%) + D(1.97b)/V(2.53b) * Rd(2.95%) * (1-Tc(0.21)))
Discount Rate = 17.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.51%
Fair Price DCF = unknown (Cash Flow -1.02b)
EPS Correlation: -74.65 | EPS CAGR: -71.44% | SUE: -4.0 | # QB: 0
Revenue Correlation: -31.17 | Revenue CAGR: -2.88% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.88 | Chg30d=-0.420 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-06-30): EPS=-3.18 | Chg30d=-1.270 | Revisions Net=+0 | Growth EPS=+0.0% | Growth Revenue=+5.7%
EPS next Year (2027-06-30): EPS=-1.85 | Chg30d=-0.345 | Revisions Net=+0 | Growth EPS=+41.7% | Growth Revenue=+11.0%